Use of Recombinant Factor VIIa for Bleeding in Children with Glanzmann Thrombasthenia
Kudret Çağlar, Ahmet Çetinkaya, Selin Aytaç, Fatma Gümrük, Aytemiz Gürgey
Abstract
Kudret Çağlar, Ahmet Çetinkaya, Selin Aytaç, Fatma Gümrük, Aytemiz Gürgey
Abstract
Glanzmann thrombasthenia is a very rare inherited platelet function disorder in which bleeding may be extremely difficult to stop. Recombinant factor VIIa is one of the alternative treatments for bleeding. The authors report here their experience with the use of factor VIIa, which may be useful for arresting bleeding in Glazmann thrombasthenia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Glanzmann thrombasthenia is a very rare inherited platelet function disorder in which bleeding may be extremely difficult to stop. Recombinant factor VIIa is one of the alternative treatments for bleeding. The authors report here their experience with the use of factor VIIa, which may be useful for arresting bleeding in Glazmann thrombasthenia.
Key concepts: Thrombasthenia, Medicine, Glanzmann's thrombasthenia, Recombinant factor VIIa, Factor VIIa, Platelet, Recombinant DNA, Surgery